Moderna Covid-19 Vaccine (Low Dose) Administration - Booster
CPT4 code
Name of the Procedure:
Moderna Covid-19 Vaccine (Low Dose) Administration - Booster
Common name(s): Moderna Booster Shot, Low Dose Covid-19 Booster
Technical term: mRNA-1273
Summary
This procedure involves receiving a low-dose booster shot of the Moderna Covid-19 vaccine. The booster is designed to enhance and prolong immunity against the Covid-19 virus, especially variants of concern.
Purpose
The procedure aims to augment and extend the protection initially provided by the primary vaccination series. The goals include reducing the risk of Covid-19 infection, preventing severe disease, hospitalization, and death, particularly in individuals who may experience waning immunity over time.
Indications
- Individuals aged 18 and older who have completed their primary vaccination series with Moderna or another approved Covid-19 vaccine.
- People at higher risk of severe Covid-19 due to age, underlying health conditions, or occupational exposure.
- Patients who have experienced a significant time lapse (typically 6 months or more) since their last Covid-19 vaccine dose.
Preparation
- Confirm eligibility for the booster dose based on the timing of the previous vaccine doses.
- Ensure the patient is not currently experiencing symptoms of Covid-19 or any other acute illness.
- Advise the patient to maintain good hydration and eat normally before the procedure.
- No mandatory fasting or extensive preparatory tests are required.
Procedure Description
- The patient checks in at the designated vaccination site and provides required identification and health information.
- A healthcare professional verifies the patient’s eligibility and records the necessary details.
- The patient is seated, and the injection site (usually the upper arm) is cleaned with an antiseptic wipe.
- Using a sterile syringe, 0.25 mL (the low-dose booster amount) of the Moderna vaccine is administered intramuscularly.
- After the injection, the patient remains at the site for a 15-30 minute observation period to monitor for any immediate adverse reactions.
Duration
The entire procedure from check-in to post-vaccination monitoring typically takes about 30-45 minutes.
Setting
The procedure is performed in various settings such as vaccination clinics, pharmacies, hospitals, or outpatient clinics.
Personnel
The booster shot administration involves:
- Registered nurses (RNs) or licensed practical nurses (LPNs)
- Pharmacists
- Medical assistants
- Occasionally supervised by a physician
Risks and Complications
Common risks:
- Pain, redness, or swelling at the injection site
- Mild fever, fatigue, or muscle aches Rare risks:
- Severe allergic reactions (anaphylaxis)
- Myocarditis or pericarditis in younger individuals
Benefits
- Enhanced immunity against Covid-19
- Reduced risk of severe disease outcomes
- Increased protection against new variants of the virus Benefits typically become noticeable within two weeks after administration.
Recovery
- Monitor for side effects for the first 24-48 hours.
- Normal activities can usually be resumed immediately, although some may experience mild flu-like symptoms.
- Follow-up is generally not required unless there are prolonged or severe side effects.
Alternatives
- Pfizer-BioNTech Covid-19 vaccine booster
- Johnson & Johnson (Janssen) Covid-19 vaccine booster
- Natural immunity from previous infection (though less recommended due to variable protection levels)
Pros and cons:
- Moderna booster offers robust and wide-ranging protection but may have a slightly higher risk of certain side effects in specific groups compared to other boosters.
Patient Experience
During the procedure, the patient might feel a slight prick or pressure at the injection site. Afterward, they may experience mild discomfort, akin to flu symptoms, that generally resolves within a few days. Pain can be managed with over-the-counter analgesics like acetaminophen or ibuprofen, if necessary. Most individuals return to normal activities shortly after receiving the booster.